Zesheng Peng

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Fusion of tumor cells and mesenchymal stem/stroma cells: a source of tumor heterogeneity, evolution and recurrence.

Fusion of tumor cells and mesenchymal stem/stroma cells: a source of tumor heterogeneity, evolution and recurrence.

Journal: Medical oncology (Northwood, London, England)

Published: October 25, 2024

PDCL3 promotes the vasculogenic mimicry of glioma-associated mesenchymal stem cells through VEGFR-2 in glioma environment.

PDCL3 promotes the vasculogenic mimicry of glioma-associated mesenchymal stem cells through VEGFR-2 in glioma environment.

Journal: iScience

Published: October 05, 2024

Fusion of glioma-associated mesenchymal stem/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m6A modification of CSF1.

Fusion of glioma-associated mesenchymal stem/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m6A modification of CSF1.

Journal: Cell death & disease

Published: September 23, 2024

Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.

Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.

Journal: PloS one

Published: August 08, 2024

Deep brain stimulation for dystonia treatment in cerebral palsy: efficacy exploration.

Deep brain stimulation for dystonia treatment in cerebral palsy: efficacy exploration.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: July 31, 2024

Identification of potential biomarkers for cerebral palsy and the development of prediction models.

Identification of potential biomarkers for cerebral palsy and the development of prediction models.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: January 12, 2024

Interventions to Facilitate Shared Decision-Making Using Decision Aids with Coronary Heart Disease Patients: Systematic Review and Meta-Analysis.

Interventions to Facilitate Shared Decision-Making Using Decision Aids with Coronary Heart Disease Patients: Systematic Review and Meta-Analysis.

Journal: Reviews in cardiovascular medicine

Published: March 10, 2023

Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.

Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.

Journal: Frontiers in immunology

Published: December 20, 2022

Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma.

Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma.

Journal: Stem cell research & therapy

Published: August 04, 2022

Identifying the Hub Genes of Glioma Peritumoral Brain Edema Using Bioinformatical Methods.

Identifying the Hub Genes of Glioma Peritumoral Brain Edema Using Bioinformatical Methods.

Journal: Brain sciences

Published: May 24, 2022

A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.

A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.

Journal: Computational and mathematical methods in medicine

Published: November 21, 2021

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas.

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas.

Journal: Frontiers in oncology

Published: August 03, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026